{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:10:45Z","timestamp":1760404245689},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,11,1]],"date-time":"1985-11-01T00:00:00Z","timestamp":499651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1985,11]]},"DOI":"10.1007\/bf00432703","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T07:08:29Z","timestamp":1100156909000},"page":"253-259","source":"Crossref","is-referenced-by-count":39,"title":["Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor ? a dose-response study in depressed patients"],"prefix":"10.1007","volume":"87","author":[{"given":"L.","family":"Bjerkenstedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Edman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Flyckt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hagenfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sedvall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"Wiesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-0447.1985.tb01282.x","volume":"71","author":"A \u00c5berg-Wistedt","year":"1985","unstructured":"\u00c5berg-Wistedt A, Alvariza M, Bertilsson L, Malmgren R, Wachtmeister H (1985) Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimelidin. Acta Psychiatr Scand 71:256?268","journal-title":"Acta Psychiatr Scand"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.4.5726.18","volume":"4","author":"M \u00c5sberg","year":"1970","unstructured":"\u00c5sberg M, Cronholm B, Sj\u00f6quist F, Tuck D (1970) Correlations of subjective side effects with plasma concentrations of nortriptyline. Br Med J 4:18?21","journal-title":"Br Med J"},{"key":"CR3","first-page":"53","volume":"7","author":"AT Beck","year":"1969","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1969) An inventory for measuring depression. Arch Gen Psychiatr 7:53?63","journal-title":"Arch Gen Psychiatr"},{"issue":"suppl 1","key":"CR4","first-page":"876","volume":"7","author":"P Bech","year":"1984","unstructured":"Bech P (1984) Citalopram versus clomipramine: A controlled clinical study. Clin Neuropharmacol 7, suppl 1:876","journal-title":"Clin Neuropharmacol"},{"key":"CR5","doi-asserted-by":"crossref","unstructured":"Bjerkenstedt L, Flyckt L, Fredricson-Over\u00f6 K, Lindgjaerde O (1985) Relations between clinical effects, serum drug concentrations and serotonin uptake inhibition in depressed patients treated with citalopram: A double-blind comparison of three dose levels. Eur J Clin Pharmacol (in press)","DOI":"10.1007\/BF00544066"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0773.1982.tb00959.x","volume":"50","author":"V Boeck","year":"1982","unstructured":"Boeck V, Fredricson-Over\u00f6 K, Svendsen O (1982) Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol 50:169?174","journal-title":"Acta Pharmacol Toxicol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00427669","volume":"82","author":"V Boeck","year":"1984","unstructured":"Boeck V, J\u00f6rgensen A, Fredricson-Over\u00f6 K (1984) Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels. Psychopharmacology 82:275?281","journal-title":"Psychopharmacology"},{"key":"CR8","first-page":"529","volume-title":"Handbuch der experimentellen Pharmakologic, 19","author":"A Carlsson","year":"1965","unstructured":"Carlsson A (1965) Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Erspamer V (ed) Handbuch der experimentellen Pharmakologic, 19. Springer, Berlin, pp 529?592"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archpsyc.1981.01780260017001","volume":"38","author":"BJ Carroll","year":"1981","unstructured":"Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatr 38:15?22","journal-title":"Arch Gen Psychiatr"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(77)90204-7","volume":"41","author":"AVB Christensen","year":"1977","unstructured":"Christensen AVB, Fjalland V, Pedersen P, Danneskiold-Sams\u00f6e P, Svendsen O (1977) Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties. Eur J Pharmacol 41:153?162","journal-title":"Eur J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-3956(72)90023-4","volume":"9","author":"G Curzon","year":"1972","unstructured":"Curzon G (1972) Relationships between stress and brain 5-hydroxytryptamine and their possible significance in affective disorders. J Psychiatr Res 9:243?252","journal-title":"J Psychiatr Res"},{"key":"CR12","doi-asserted-by":"crossref","unstructured":"de Wilde J, Mertens C, Fredricson-Over\u00f6 K, H\u00f6pfner-Petersen HE (1985) Citalopram versus mianserin. A controlled double-blind trial in depressed patients. Acta Psychiatr Scand (in press)","DOI":"10.1111\/j.1600-0447.1985.tb02576.x"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(76)90005-6","volume":"113","author":"A Dray","year":"1976","unstructured":"Dray A, Gonye TJ, Oakley NR, Tanner T (1976) Evidence for the existence of raphe projection to the substantia nigra in rat. Brain Res 113:45?57","journal-title":"Brain Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1471-4159.1978.tb10489.x","volume":"30","author":"JD Fernstrom","year":"1978","unstructured":"Fernstrom JD, Faller DV (1978) Neutral amino acids in the brain: Changes in response to food ingestion. J Neurochem 30:1531?1538","journal-title":"J Neurochem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1126\/science.178.4059.414","volume":"178","author":"JD Fernstrom","year":"1972","unstructured":"Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178:414?416","journal-title":"Science"},{"issue":"suppl 247","key":"CR16","first-page":"37","volume":"64","author":"K Fuxe","year":"1965","unstructured":"Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. Acta Physiol Scand 64, suppl 247:37?85","journal-title":"Acta Physiol Scand"},{"key":"CR17","volume-title":"New vistas in depression","author":"K Fuxe","year":"1982","unstructured":"Fuxe K, \u00d6gren SO, Agnati R, Andersson R, Eneroth P (1982) On the mechanism of action of antidepressant drugs: Indications of reductions in 5-HT neurotransmission in some brain regions upon subchronic treatment. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, New York"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0278-5846(82)80182-6","volume":"6","author":"M Gastpar","year":"1982","unstructured":"Gastpar M, Gastpar G (1982) Preliminary studies with Citalopram (Lu 10-171), as specific 5-HT reuptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiatr 6:319?325","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatr"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0447.1980.tb00611.x","volume":"62","author":"P Gottlieb","year":"1980","unstructured":"Gottlieb P, Wandall T, Fredricson-Over\u00f6 K (1980) Initial, clinical trial of a new specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 62:236?244","journal-title":"Acta Psychiatr Scand"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/0024-3205(66)91026-5","volume":"5","author":"MC Guldberg","year":"1966","unstructured":"Guldberg MC, Ashcroft GW, Crawford TBB (1966) Concentrations of 5-hydroxyindolyl acetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci 5:1571?1575","journal-title":"Life Sci"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1192\/bjp.121.2.162","volume":"121","author":"C Gurney","year":"1972","unstructured":"Gurney C, Roth M, Garside RF, Kerr TA, Schapira K (1972) Studies in the classification of affective disorders. The relationship between state and depressive illnesses. Br J Psychiatr 121:162?166","journal-title":"Br J Psychiatr"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1471-4159.1984.tb02756.x","volume":"42","author":"L Hagenfeldt","year":"1984","unstructured":"Hagenfeldt L, Bjekenstedt L, Edman G, Sedvall G, Wiesel FA (1984) Amino acids and monoamine metabolites in CSF-interrelationship in healthy subjects. J Neurochem 42:833?837","journal-title":"J Neurochem"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0447.1984.tb06860.x","volume":"69","author":"C H\u00e4rnryd","year":"1984","unstructured":"H\u00e4rnryd C, Bjerkenstedt L, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA (1984) Time course for effects of sulpiride and chlorpromazine on monamine metabolite and prolactin levels in cerbrospinal fluid from schizophrenic patients. Acta Psychiatr Scand 69:75?92","journal-title":"Acta Psychiatr Scand"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/08039487809106576","volume":"32","author":"HE H\u00f6pfner-Petersen","year":"1978","unstructured":"H\u00f6pfner-Petersen HE, Fredricson-Over\u00f6 K, Hyttel J (1978) Citalopram?en mulighed fur vudering af 5-HT teoriens anvendlighed ved depressionsbehandling. Nord Psykiat T 32:463?471","journal-title":"Nord Psykiat T"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00431629","volume":"51","author":"J Hyttel","year":"1977","unstructured":"Hyttel J (1977a) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology 51:225?233","journal-title":"Psychopharmacology"},{"key":"CR26","first-page":"439","volume":"40","author":"J Hyttel","year":"1977","unstructured":"Hyttel J (1977b) Effect of a selective 5-HT uptake inhibitor ? Lu 10-171 ? on rat brain 5-HT turnover. Acta Pharmacol Toxicol 40:439?446","journal-title":"Acta Pharmacol Toxicol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00429172","volume":"60","author":"J Hyttel","year":"1978","unstructured":"Hyttel J (1978) Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60:13?18","journal-title":"Psychopharmacology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0024-3205(81)90150-8","volume":"28","author":"J Hyttel","year":"1981","unstructured":"Hyttel J (1981) Similarities between the binding of 3H-pifluxitol and 3H-flupentixol to rat striatal dopamine receptors in vitro. Life Sci 28:563?569","journal-title":"Life Sci"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0278-5846(82)80178-4","volume":"6","author":"J Hyttel","year":"1982","unstructured":"Hyttel J (1982) Citalopram, pharmacological profile of specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatr 6:275?336","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.7444441","volume":"210","author":"SZ Langer","year":"1980","unstructured":"Langer SZ, Moret C, Raisman R, Dubocovik ML, Burley M (1980) High affinity (3H)-imipramine binding in rat hypothalamus: Association with uptake of serotonin but not of norepinephrine. Science 210:1133?1135","journal-title":"Science"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","volume":"i","author":"IP Lapin","year":"1969","unstructured":"Lapin IP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as possible determinant of the thymoleptic effect. Lancet i:132?136","journal-title":"Lancet"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-1781(83)90136-1","volume":"8","author":"WP Leighton","year":"1983","unstructured":"Leighton WP, Rosenblatt S, Chanley JD (1983) Lithium-induced changes in plasma amino acid levels during treatment of affective disorders. Psychiatr Res 8:33?40","journal-title":"Psychiatr Res"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00464566","volume":"77","author":"O Lindegaard-Pedersen","year":"1982","unstructured":"Lindegaard-Pedersen O, Kragh-S\u00f6rensen P, Bjerre M, Fredricson-Over\u00f6 K, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor; clinical antidepressive and long-term effect ? a phase II study. Psychopharmacology 77:199?204","journal-title":"Psychopharmacology"},{"issue":"suppl 280","key":"CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.1980.61.s280.97","volume":"61","author":"L Maitre","year":"1980","unstructured":"Maitre L, Moser P, Baumann PA, Waldmeier PC (1980) Amine uptake inhibitors: Criteria of selectivity. Acta Psychiatr Scand 61, suppl 280:97?110","journal-title":"Acta Psychiatr Scand"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0327(80)90021-X","volume":"2","author":"SE M\u00f6ller","year":"1980","unstructured":"M\u00f6ller SE, Kirk L, Honore P (1980) Relationship between plasma ratio of tryptophan to competing amino acids and the response to l-trypophan treatment in endogenously depressed patients. J Affect Dis 2:47?59","journal-title":"J Affect Dis"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0327(83)90038-1","volume":"5","author":"SR M\u00f6ller","year":"1983","unstructured":"M\u00f6ller SR, Honore P, Larsen OB (1983) Tryptophan and tyrosine ratios to neutral amino acids in endogenously depression. J Affect Dis 5:67?79","journal-title":"J Affect Dis"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-0327(81)90025-2","volume":"3","author":"SE M\u00f6ller","year":"1981","unstructured":"M\u00f6ller SE, Reisby N, Ortmann J, Elley J, Krautwald O (1981) Relevance of tryptophan and tyrosine availability in endogenous and ?nonendogenous? depressive treated with imipramine and clomipramine. J Affect Dis 3:231?243","journal-title":"J Affect Dis"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr 134:382?389","journal-title":"Br J Psychiatr"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0278-5846(82)80183-8","volume":"6","author":"E \u00d6fsti","year":"1982","unstructured":"\u00d6fsti E (1982) Citalopram ? a specific 5-HT reuptake inhibitor ? as an antidepressant drug: A phase II multicentre trial. Prog Neuro-Psychopharmacol Biol Psychiatr 6:327?335","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatr"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1471-4159.1977.tb07702.x","volume":"28","author":"WM Pardridge","year":"1977","unstructured":"Pardridge WM, Oldendorf WH (1977) Transport of metabolic substrates through the blood brain barrier. J Neurochem 28:5?12","journal-title":"J Neurochem"},{"key":"CR41","first-page":"753","volume":"39","author":"RB Rastogi","year":"1981","unstructured":"Rastogi RB, Singhal RL, Lapierre YD (1981) Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: Focus on the serotonin hypothesis of schizophrenia. Life Sci 39:753?741","journal-title":"Life Sci"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00422153","volume":"32","author":"J Schubert","year":"1973","unstructured":"Schubert J (1973) Effect of chronic lithium treatment on monoamine metabolism in rat brain. Psychopharmacology 32:301?311","journal-title":"Psychopharmacology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-7158.1970.tb08410.x","volume":"22","author":"J Schubert","year":"1970","unstructured":"Schubert J, Nyb\u00e4ck H, Sedvall G (1970) Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain. J Pharm Pharmacol 22:136?139","journal-title":"J Pharm Pharmacol"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Wilk MB (1965) An analysis of variance test for normality (complete samples). Biometrika 52:591?611","journal-title":"Biometrika"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000468267","volume":"6","author":"F Sj\u00f6qvist","year":"1971","unstructured":"Sj\u00f6qvist F (1971) A pharmacokinetic approach to the treatment of depression. Int Pharmacopsychiatr 6:147?169","journal-title":"Int Pharmacopsychiatr"},{"key":"CR46","doi-asserted-by":"crossref","unstructured":"Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria (RDC) for a selected group of functional disorders, 3rd edition. New York State Psychiatric Institute","DOI":"10.1037\/t04137-000"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00423253","volume":"48","author":"CG Swahn","year":"1976","unstructured":"Swahn CG, Sandg\u00e4rde B, Wiesel FA, Sedvall G (1976) Simultaneous determination of three major monoamine metabolites in brain tissue and body fluids by mass fragmentographic methods. Psychopharmacology 48:157?162","journal-title":"Psychopharmacology"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/BF01965988","volume":"36","author":"PC Waldmeier","year":"1980","unstructured":"Waldmeier PC (1980) Serotonergic modulation of mesolimbic and frontal cortical dopamine neurons. Experentia 36:1092?1094","journal-title":"Experentia"},{"key":"CR49","volume-title":"Statistical principles in experimental design","author":"BJ Winer","year":"1971","unstructured":"Winer BJ (1971) Statistical principles in experimental design, 2nd edition. New York, McGraw Hill","edition":"2nd edition"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00432703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00432703\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00432703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T00:23:22Z","timestamp":1585959802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00432703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["BF00432703"],"URL":"https:\/\/doi.org\/10.1007\/bf00432703","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}